Shares of Mydecine Innovations Group Inc. (OTCMKTS:MYCOF – Get Free Report) fell 8.8% on Tuesday . The company traded as low as $0.73 and last traded at $0.73. Mydecine Innovations Group Price PerformanceThe company has a fifty day moving average price of $1.47 and a two-hundred day moving average price of $0.97. Get Mydecine Innovations Group alerts:About Mydecine Innovations Group(Get Free Report)Mydecine Innovations Group (OTCMKTS:MYCOF) is a clinical‐stage biotechnology company dedicated to the research, development and commercialization of novel therapeutics derived from psychedelic and plant-based compounds. Featured ArticlesReceive News & Ratings for Mydecine Innovations Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mydecine Innovations Group and related companies with MarketBeat.com's FREE daily email newsletter.